Background: The introduction of effective highly active antiretroviral therapy (HAART) in the mid 1990s lead to the marked reduction in the morbidity and mortality from human immunodeficiency virus (HIV) infection. Increasing life expectancy, an aging population, and high rates of smoking have lead to concerns of the health of HIV infected individuals in the long run. Metabolic effects of HIV infection such as hypertriglyceridemia are well defined and side effects of HAART such as dyslipidemia and were described soon after its introduction. Aim: To study the lipid profile of HIV/AIDS patients on antiretroviral therapy. Results: 120 patients are studied for period of 18 months. 66.7% patients have Hypercholesterolemia and 33.3% have in the normal range. 80% of the patients have HDL below the normal range and 20% have in the normal range. 70% of the patients have hypertriglyceridemia and 30% have within the normal range. 60% of patients have LDL in the abnormal range and 40% in the normal range. 5.8% of the patients have VLDL within abnormal range and 94.2% have it within the normal range. Males are more affected than females. The patients in the young age group are more affected than patients in the older group.

Demyelinating diseases like Multiple Sclerosis and cases of long segment myelitis, neuromuscular disease like Myasthenia Gravis and Autoimmune Encephalitis have an autoimmune basis and occur in a relapsing remitting course. Achieving and maintaining

Seizures are due to abnormal excessive and synchronous neuronal activity in the brain [1]. Outward effects vary from uncontrolled shaking movements involving much of the body with loss of consciousness, to shaking movements involving only part of the body with variable levels of consciousness, to a subtle momentary loss of awareness. Up to 10% of people have at least one epileptic seizure in their lifetime out of which 50% have a recurrence [2].